• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经济补偿会提高对结直肠癌筛查的参与度。

Pecuniary compensation increases participation in screening for colorectal cancer.

作者信息

Aas Eline

机构信息

Institute of Health Management and Health Economics, University of Oslo, Oslo, Norway.

出版信息

Health Econ. 2009 Mar;18(3):337-54. doi: 10.1002/hec.1371.

DOI:10.1002/hec.1371
PMID:18677722
Abstract

The participation rate in medical screening programmes is typically below 100%, which means that not all potential health benefits are fully exploited. In this paper, the prospect of pecuniary compensation is tested as a method of increasing the participation rate. We propose a model explaining the individual's probability of participating in screening for colorectal cancer when he is offered pecuniary compensation, given that he did not participate when first invited. The participant's decision is based on both known and uncertain factors. The estimation is conducted in two steps, where a binary probit model is used in each. We find that pecuniary compensation increases the probability of participation, and that an individual's participation probability systematically varies with variables such as travel expenses, income, age, education level, expected benefit from the screening, use of health-care services, genetic predisposition and subjective health status. Using the results from the estimation, we predict changes in the participation rate for different levels of compensation and estimate the cost per additional individual screened. The cost per additional individual screened is 808, including 25 in compensation; this cost increases with the level of compensation.

摘要

医学筛查项目的参与率通常低于100%,这意味着并非所有潜在的健康益处都能得到充分利用。在本文中,对金钱补偿前景作为提高参与率的一种方法进行了测试。我们提出了一个模型,用于解释个人在首次被邀请时未参与,而在获得金钱补偿后参与结直肠癌筛查的概率。参与者的决策基于已知和不确定因素。估计分两步进行,每一步都使用二元概率模型。我们发现金钱补偿会增加参与概率,并且个人的参与概率会随着诸如差旅费、收入、年龄、教育水平、筛查预期收益、医疗服务使用情况、遗传易感性和主观健康状况等变量而系统地变化。利用估计结果,我们预测了不同补偿水平下的参与率变化,并估计了每多筛查一名个体的成本。每多筛查一名个体的成本为808,其中补偿为25;此成本会随着补偿水平的提高而增加。

相似文献

1
Pecuniary compensation increases participation in screening for colorectal cancer.经济补偿会提高对结直肠癌筛查的参与度。
Health Econ. 2009 Mar;18(3):337-54. doi: 10.1002/hec.1371.
2
Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.太白山研讨会:结直肠癌筛查的障碍——经济学、能力与依从性
J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S198-204. doi: 10.1111/j.1440-1746.2008.05556.x.
3
Informed decision-making and colorectal cancer screening: is it occurring in primary care?知情决策与结直肠癌筛查:在初级保健中是否正在发生?
Med Care. 2008 Sep;46(9 Suppl 1):S23-9. doi: 10.1097/MLR.0b013e31817dc496.
4
Modeling the decision to undergo colorectal cancer screening: insights on patient preventive decision making.模拟接受结直肠癌筛查的决策:对患者预防性决策的见解
Med Care. 2008 Sep;46(9 Suppl 1):S17-22. doi: 10.1097/MLR.0b013e31817eb332.
5
Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.不参与粪便潜血试验结直肠癌筛查项目的低优先级主要原因。
J Public Health (Oxf). 2008 Dec;30(4):461-5. doi: 10.1093/pubmed/fdn063. Epub 2008 Aug 20.
6
To participate or not? Giving voice to gender and socio-economic differences in colorectal cancer screening programmes.是否参与?在结直肠癌筛查计划中表达性别和社会经济差异的声音。
Eur J Cancer Care (Engl). 2011 Sep;20(5):669-78. doi: 10.1111/j.1365-2354.2011.01263.x. Epub 2011 Jul 19.
7
Colorectal cancer screening: bring practice in line with the evidence.结直肠癌筛查:使实践与证据相符。
Dis Manag Advis. 2003 Jul;9(7):96-9, 93.
8
The effect of neighborhood, socioeconomic status and a community-based program on multi-disease health screening in an Asian population: a controlled intervention study.社区、社会经济地位和基于社区的计划对亚洲人群多种疾病健康筛查的影响:一项对照干预研究。
Prev Med. 2011 Jul-Aug;53(1-2):64-9. doi: 10.1016/j.ypmed.2011.05.005. Epub 2011 May 23.
9
Participation in a sigmoidoscopic colorectal cancer screening program: a pilot study.参与乙状结肠镜结直肠癌筛查项目:一项试点研究。
Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1127-30.
10
Willingness to undergo colorectal cancer screening in first-degree relatives of hospitalized patients with colorectal cancer.结直肠癌住院患者一级亲属接受结直肠癌筛查的意愿。
J Med Screen. 2009;16(1):33-8. doi: 10.1258/jms.2009.008062.

引用本文的文献

1
The effect of physician density on colorectal cancer stage at diagnosis: causal inference methods for spatial data applied on regional-level data.医生密度对结直肠癌诊断时分期的影响:应用于区域水平数据的空间数据因果推理方法。
Int J Health Geogr. 2023 Jan 19;22(1):1. doi: 10.1186/s12942-023-00323-w.
2
Characteristics of nonparticipants in a randomised colorectal cancer screening trial comparing sigmoidoscopy and faecal immunochemical testing.随机对照结直肠癌筛查试验中不参与者的特征比较,该试验比较乙状结肠镜检查和粪便免疫化学检测。
Int J Cancer. 2022 Aug 1;151(3):361-371. doi: 10.1002/ijc.34025. Epub 2022 Apr 22.
3
Is distance to chemotherapy an obstacle to adjuvant care among the N.C. Medicaid-enrolled colon cancer patients?
对于北卡罗来纳州医疗补助计划覆盖的结肠癌患者而言,距离化疗地点的远近是否会成为辅助治疗的障碍?
J Gastrointest Oncol. 2016 Jun;7(3):336-44. doi: 10.21037/jgo.2016.02.01.
4
Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway.挪威人乳头瘤病毒初筛用于宫颈癌筛查的成本效益分析。
Br J Cancer. 2012 Apr 24;106(9):1571-8. doi: 10.1038/bjc.2012.94. Epub 2012 Mar 22.